Key Ruling Foils GSK Zofran MDL Ahead Of Bellwether
By Chris Villani · June 1, 2021, 5:33 PM EDT
GlaxoSmithKline will not have to face more than 420 suits in multidistrict litigation alleging its anti-nausea medication Zofran causes birth defects after a Massachusetts federal judge ruled Tuesday the claims are preempted...
To view the full article, register now.